SIALIC ACID DERIVATIVES

Details for Australian Patent Application No. 2002255344 (hide)

Owner SANKYO COMPANY, LIMITED

Inventors HONDA, Takeshi; MASUDA, Takeshi; YAMASHITA, Makoto

Pub. Number AU-A-2002255344

PCT Pub. Number WO2002/092555

Priority 2001-141384 11.05.01 JP

Filing date 10 May 2002

Wipo publication date 25 November 2002

International Classifications

C07C 279/24 Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups

A61K 031/351 - not condensed with another ring

A61K 031/16 - Amides, e.g. hydroxamic acids

A61P 043/00 Drugs for specific purposes, not provided for in groups

C07D 309/28 Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

A61K 031/196

A61K 031/27

Event Publications

1 May 2003 Application Open to Public Inspection

  Published as AU-A-2002255344

4 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002255345-BIOMOLECULAR SUBSTRATE AND METHOD AND APPARATUS FOR EXAMINATION AND DIAGNOSIS USING THE SAME

2002255343-METHOD OF FORMING STABLE COMPLEX OF TRANSCRIPTION PRODUCT OF DNA ENCODING ARBITRARY PEPTIDE WITH TRANSLATION PRODUCT, NUCLEIC ACID CONSTRUCT TO BE USED IN THE METHOD, COMPLEX FORMED BY THE METHOD, AND SCREENING OF FUNCTIONAL PROTEIN AND MRNA OR DNA ENCODING THE PROTEIN USING THE METHOD